NIDAN — Nidan Laboratories and Healthcare Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Market Cap
IN₹267.58m
Enterprise Value
IN₹374.57m
Revenue
IN₹245.28m

Annual income statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	204	297	243	242	245
Cost of Revenue
Gross Profit	182	266	232	232	238
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	72.2	92.8	61.3	150	54.8
Operating Profit	132	204	181	91.8	190
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33	45.2	48.1	-23.7	27.6
Provision for Income Taxes
Net Income After Taxes	23	26.6	35.4	-32.3	19.8
Net Income Before Extraordinary Items
Net Income	23	26.6	35.4	-32.3	19.8
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	23	26.6	35.4	-32.3	19.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.66	2.17	2.4	0.722	1.41
Dividends per Share